EUVIMEDEUVIMED entdecken
Crossref

Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADME Predictions of Huperzine: A Derivative for the Novel Protective Application Against Neurodegenerations

Benjaporn Homkajorn, Thanasan Nilsu, Sumitra Suntararuks, Patchreenart Saparpakorn, Kornkanok Ingkaninan, Nanteetip Limpeanchob, Jutamaad Satayavivad, Somsak Ruchirawat, Nopporn Thasana iD

Chemistry – An Asian Journal · 2025

DOI: 10.1002/asia.202401950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2025. Verfasst von Benjaporn Homkajorn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, 10210, Thailand. Hauptthemen laut MEDLINE: Alkaloids, Molecular Docking Simulation, Sesquiterpenes, Neuroprotective Agents. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Thailand Science Research and Innovation, Ministry of Higher Education, Science, Research and Innovation, Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To date, there has been no effective treatment available for the Alzheimer's disease (AD); hence, novel compounds with AD inhibitory effects are highly desirable. Huperzine A (HupA), a natural Lycopodium alkaloid, is a potent acetylcholinesterase (AChE) inhibitor for AD treatment. In this study, HupA derivatives, huperzil, N ‐hippurylhuperzine A, pyrrolhuperzine A, maleicamide‐huperzine A and phthaleicamide‐huperzine A, were synthesized and their in silico computation as the central nervous system (CNS) drug was performed. All derivatives exhibited lower anti‐AChE activity than HupA. However, we found other non‐cholinergic functions in AD‐mimicking models using differentiated SH‐SY5Y. HupA and derivatives significantly suppressed the Aβ 25‐35 cytotoxicity and showed recovery effects against arsenic‐ induced AD pathologies including reactive oxygen species generation, neurite outgrowth shortening, amyloid precursor protein suppression and the elevation of β ‐secretase, endogenous Aβ peptide, and Tau and neurofilament light proteins. In summary, we prepared three potential compounds with dual‐AChE cholinergic and non‐cholinergic functions. Further development of these compounds will be beneficial for the future use as an alternate compound against AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkaloidsMolecular Docking SimulationSesquiterpenesNeuroprotective AgentsCholinesterase InhibitorsHumansAcetylcholinesteraseAmyloid beta-PeptidesAlzheimer DiseaseMolecular StructureCell Line, TumorReactive Oxygen SpeciesStructure-Activity RelationshipCell SurvivalPeptide Fragments

Stichwörter der Autor:innen

Alzheimer's disease (AD)Anti‐AD compoundsBiological evaluationHuperzine A derivativesNeurodegeneration

Substanzen

huperzine AAlkaloidsSesquiterpenesNeuroprotective AgentsCholinesterase InhibitorsAcetylcholinesteraseAmyloid beta-PeptidesReactive Oxygen SpeciesPeptide Fragmentsamyloid beta-protein (25-35)

Autor:innen und Institutionen

  • Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, 10210, Thailand.
  • Applied Biological Sciences Program, Chulabhorn Graduate Institute, Bangkok, 10210, Thailand.
  • Department of Chemistry, Faculty of Science, Kasetsart University, Bangkok, 10900, Thailand.
  • Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, 65000, Thailand.
  • Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Center of Excellence for Innovation in Chemistry, Naresuan University, Phitsanulok, 65000, Thailand.
  • Center of Excellence on Environmental Health and Toxicology (EHT), OPS, Ministry of Higher Education, Science, Research and Innovation, Bangkok, 10210, Thailand.

ORCID-Profile: Nopporn Thasana

Förderung

  • Thailand Science Research and Innovation
  • Ministry of Higher Education, Science, Research and Innovation, Thailand

Zitieren

APA

Homkajorn, B., Nilsu, T., Suntararuks, S., Saparpakorn, P., Ingkaninan, K., Limpeanchob, N., Satayavivad, J., Ruchirawat, S., & Thasana, N. (2025). Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADME Predictions of Huperzine: A Derivative for the Novel Protective Application Against Neurodegenerations. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202401950

Vancouver

Homkajorn B, Nilsu T, Suntararuks S, Saparpakorn P, Ingkaninan K, Limpeanchob N, et al. Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADME Predictions of Huperzine: A Derivative for the Novel Protective Application Against Neurodegenerations. Chemistry – An Asian Journal. 2025. doi:10.1002/asia.202401950

BibTeX
@article{Homkajorn2025,
  author = {Homkajorn, Benjaporn and Nilsu, Thanasan and Suntararuks, Sumitra and Saparpakorn, Patchreenart and Ingkaninan, Kornkanok and Limpeanchob, Nanteetip and Satayavivad, Jutamaad and Ruchirawat, Somsak and Thasana, Nopporn},
  title = {Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADME Predictions of Huperzine: A Derivative for the Novel Protective Application Against Neurodegenerations},
  journal = {Chemistry – An Asian Journal},
  year = {2025},
  doi = {10.1002/asia.202401950}
}
Kostenlos starten →